Myriad, Chronix Sign Licensing Agreement
Myriad Genetics Inc has signed an agreement to license proprietary technology for the early detection of cancer from Chronix Biomedical.
Read MorePosted by Clinical Lab Products | May 16, 2011 | Cancer, Miscellaneous |
Myriad Genetics Inc has signed an agreement to license proprietary technology for the early detection of cancer from Chronix Biomedical.
Read MorePosted by Clinical Lab Products | May 9, 2011 | Cancer, Miscellaneous |
G-BioscienceBioCare Medical LLC
Read MorePosted by Clinical Lab Products | May 1, 2011 | Cancer, Miscellaneous |
BioCare Medical LLC offers a new look at prostate cancer diagnosis.
Read MorePosted by Clinical Lab Products | Apr 5, 2011 | Cancer, Miscellaneous |
From the exhilaration of a fantasy vacation in Thailand and Cambodia—which happened to include being all shook up about 20 miles from the epicenter of the 6.8-magnitude Myanmar earthquake that struck the evening of March 24—I came
Read MorePosted by Clinical Lab Products | Feb 4, 2011 | Cancer, Miscellaneous |
An industry veteran and clinical oncologist, Dr. Cowens will drive the development of the company’s pipeline of molecular diagnostics for cancer.
Read More